What are the inflammation-reducing topical applications for nasal polyps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Topical corticosteroid sprays are the first-line treatment for reducing inflammation in nasal polyps, with fluticasone propionate (Flonase) 1-2 sprays per nostril daily or mometasone furoate (Nasonex) 2 sprays per nostril daily being recommended options, as supported by the most recent and highest quality study 1. The use of topical corticosteroids for nasal polyps is well-established, with a strong evidence base demonstrating their effectiveness in reducing symptoms and improving quality of life 1.

  • Key benefits of topical corticosteroids include:
    • Reducing inflammation by suppressing inflammatory cell recruitment, decreasing cytokine production, and inhibiting inflammatory mediators
    • Shrinking polyps and improving nasal breathing
    • Minimizing adverse events, which are generally minor and may include epistaxis, headache, and nasal itching
  • Proper administration technique is crucial, and patients should be instructed to:
    • Shake the bottle before use
    • Keep their head upright during application
    • Direct the spray away from the septum
    • Breathe in gently during application
  • For severe cases, a short course of oral steroids like prednisone (20-40mg daily for 5-7 days) may be prescribed initially to reduce polyp size before starting topical therapy, as suggested by 1.
  • Saline nasal irrigation twice daily before using the steroid spray can improve medication delivery, as noted in 1.
  • If symptoms persist after 3 months of consistent use, consulting a doctor for consideration of biologics like dupilumab may be necessary for refractory cases.

From the FDA Drug Label

Corticosteroids are natural substances found in the body that help fight inflammation. Fluticasone propionate is a synthetic, trifluorinated corticosteroid with anti-inflammatory activity. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.

The fluticasone propionate nasal spray can be used as an inflammation-reducing topical application in patients with nasal polyps, as it has anti-inflammatory activity.

  • The spray works by reducing the symptoms of allergic reactions and the stuffiness, runniness, itching, and sneezing that can bother patients with rhinitis.
  • Fluticasone propionate has been shown to decrease nasal mucosal eosinophils and basophils in patients with allergic rhinitis 2, 2.
  • It is essential to use the spray as directed by a doctor and follow the instructions provided with the medication.

From the Research

Inflammation Reducing Topical Applications in Nasal Polyp Treatment

  • Topical corticosteroids have been shown to be effective in reducing inflammation and polyp size in patients with nasal polyps 3, 4, 5.
  • The mechanism of action of corticosteroids involves binding to a specific cytoplasmic glucocorticoid receptor, leading to a reduction in the number of antigen-presenting cells, T cells, mast cells, and eosinophils 3.
  • Topical corticosteroids such as betamethasone sodium phosphate nose drops, beclomethasone dipropionate, fluticasone propionate, and budesonide nasal sprays have been demonstrated to be effective in reducing polyp size and rhinitis symptoms 3, 5.
  • Beclomethasone dipropionate, flunisolide, and budesonide sprays have also been shown to delay the recurrence of polyps after surgery 3, 5.

Benefits of Topical Corticosteroids

  • Topical corticosteroids improve overall symptom scores and reduce polyp size 4.
  • They also prevent polyp recurrence after surgery 4.
  • Subgroup analyses have shown that patients who have undergone sinus surgery may have a greater response to topical corticosteroids 4.
  • Topical corticosteroids are generally well-tolerated, with minor adverse effects 4, 6.

Current Recommendations

  • Intranasal saline irrigations and topical steroids are mainstays of CRSwNP treatment 6.
  • Alternative steroid delivery methods and adjunctive treatments may be beneficial for certain patient populations, but more research is needed to confirm their effectiveness 6.
  • Topical steroid therapy is clearly effective for CRSwNP, and recent studies demonstrate the safety and efficacy of high-dose nasal steroid rinses 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical steroids for nasal polyps.

The Cochrane database of systematic reviews, 2012

Research

State of the Art Medical Management of Nasal Polyps.

American journal of rhinology & allergy, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.